Answers are grounded in this paper and cite their sources.
The longitudinal relationship between antipsychotic treatment patterns, such as polypharmacy and use of long-acting injectable (LAI) antipsychotics, and real-world functional outcomes is insufficiently explored. We conducted a single-center 10-year retrospective study including 114 patients with chronic schizophrenia. Monthly Global Assessment of Functioning (GAF) scores were assessed (>122 months), alongside antipsychotic patterns [polypharmacy, LAI, and chlorpromazine-equivalent (CPeq)]. A lagged linear mixed-effects model tested whether prior-month treatment predicted next-month GAF. Ordinary least squares regression assessed cumulative exposure with final GAF and 10-year change. Subgroup analyses were stratified by duration of untreated psychosis (DUP). Subsequent GAF scores showed significant positive associations with 1-month lagged polypharmacy (estimate = +1.50, standard error (SE) = 0.14, p < .001) and 1-month lagged use of LAI (estimate = +1.89, SE = 0.27, p < .001), and a significant negative association with lagged CPeq dosage (estimate = 3.7 × 10 -3 , SE = 1.8 × 10 -4 , p < .001). Hospitalizations were negatively associated with functional outcome (β = -0.24, p = .038). Cumulative polypharmacy, use of LAIs, and CPeq dose were not significantly associated with either final GAF or 10-year GAF change. Using stratified analyses by DUP, all models showed no statistically significant results; however, educational level and number of hospitalizations modulated long-term functional outcomes in the DUP <12 months group. Short-term GAF improvement was linked to polypharmacy and use of LAI, whereas higher doses predicted poorer functioning. DUP-based subgroup models showed no significant results overall. • One-month lag_polypharmacy was positively associated with subsequent GAF scores. • One-month lag_LAI was positively associated with subsequent GAF scores. • Lagged CPeq dosage was negatively associated with subsequent GAF scores. • The number of hospitalizations was negatively associated with functional outcome. • Short-term GAF improvement may be positively impacted by polypharmacy and LAI use.
No takes yet. Share an insight, caveat, or question.
Mori et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: